Armata Pharma reports positive data from phase 1b/2a diSArm study of intravenously administered AP-SA02 to treat S. aureus bacteremia: Los Angeles Tuesday, May 20, 2025, 17:00 Hrs ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs ...

Armata Pharmaceuticals has posted early validation of its phage platform. The phase 1b/2a trial linked a bacteriophage ...

Repeated perinatal antibiotic exposure in very low-birth-weight preterm infants was associated with impaired lung function ...

This is a summary of “Epidemiology and prediction of non-targeted bacteria by the filmarray pneumonia plus panel in culture-positive ventilator-associated pneumonia: a retrospective multicentre ...

Discover the 4 stages of appendicitis, from early inflammation to life-threatening rupture, and learn 6 warning signs that ...

Antibiotics have revolutionised the prevention and treatment of bacterial infections, made routine surgeries, transplants, ...

Exposure to antibiotics following FMT may lead to recurrent CDI, suggesting the need for modified strategies to prevent recurrent CDI in some patients.

Marley Mansour, 11, is one of fewer than 100 people in the world with a particular mutation in the NARS1 gene. She's set to ...

Discover the essential facts about chancroid, a lesser-known but serious STI that causes painful genital ulcers and increases ...

Focusing on a new antibiotic for UTIs, which haven’t had a novel therapy in decades, was intentional, Walmsley says. Half of ...

Risk seen for asthma, food allergies, allergic rhinitis, and intellectual disability. HealthDay News — Children receiving multiple antibiotic courses between birth and age 2 years may have a higher ...